Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Biogen taps Royalty for $250M to fund phase 3 lupus program
The cash will bankroll phase 3 development of a lupus candidate that Biogen has named in a bunch of assets with potential peak sales of $14 billion.
Nick Paul Taylor
Feb 12, 2025 8:10am
GSK plots move of vaccine R&D from Maryland to Massachusetts
Feb 11, 2025 1:40pm
Sponsored
Carl Sailer on AI, market trends, and strategic planning in biotech
Oct 28, 2024 8:00pm
Pfizer shares prostate cancer data after leak, inks Alloy deal
Feb 11, 2025 1:07pm
Sponsored
Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization
Oct 28, 2024 8:00am
Fierce Biotech Layoff Tracker 2025: Inventiva, Q32 Bio & more
Feb 11, 2025 10:30am